AMRX logo

Amneal Pharmaceuticals (AMRX) Cash from financing

annual CFF:

-$211.79M+$782.00K(+0.37%)
December 31, 2024

Summary

  • As of today (May 29, 2025), AMRX annual cash flow from financing activities is -$211.79 million, with the most recent change of +$782.00 thousand (+0.37%) on December 31, 2024.
  • During the last 3 years, AMRX annual CFF has fallen by -$73.67 million (-53.34%).
  • AMRX annual CFF is now -173.62% below its all-time high of $287.68 million, reached on December 31, 2018.

Performance

AMRX Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXcash flow metrics

quarterly CFF:

-$39.17M+$22.04M(+36.01%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AMRX quarterly cash flow from financing activities is -$39.17 million, with the most recent change of +$22.04 million (+36.01%) on March 31, 2025.
  • Over the past year, AMRX quarterly CFF has dropped by -$16.01 million (-69.15%).
  • AMRX quarterly CFF is now -108.37% below its all-time high of $467.98 million, reached on March 31, 2020.

Performance

AMRX quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXcash flow metrics

TTM CFF:

-$227.80M-$16.01M(-7.56%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AMRX TTM cash flow from financing activities is -$227.80 million, with the most recent change of -$16.01 million (-7.56%) on March 31, 2025.
  • Over the past year, AMRX TTM CFF has dropped by -$4.97 million (-2.23%).
  • AMRX TTM CFF is now -144.97% below its all-time high of $506.60 million, reached on September 30, 2018.

Performance

AMRX TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

AMRX Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+0.4%-69.2%-2.2%
3 y3 years-53.3%+36.4%-31.3%
5 y5 years-362.1%-108.4%-151.3%

AMRX Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-98.6%+0.4%-268.5%+61.2%-293.1%+9.4%
5 y5-year-260.7%+0.4%-108.4%+87.4%-151.3%+37.1%
alltimeall time-173.6%+0.4%-108.4%+87.4%-145.0%+37.1%

AMRX Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$39.17M(-36.0%)
-$227.80M(+7.6%)
Dec 2024
-$211.79M(-0.4%)
-$61.20M(-33.7%)
-$211.79M(-15.8%)
Sep 2024
-
-$92.35M(+163.2%)
-$251.42M(+2.3%)
Jun 2024
-
-$35.09M(+51.5%)
-$245.66M(+10.2%)
Mar 2024
-
-$23.16M(-77.0%)
-$222.83M(+4.8%)
Dec 2023
-$212.57M(+99.4%)
-$100.83M(+16.5%)
-$212.57M(+58.7%)
Sep 2023
-
-$86.58M(+606.5%)
-$133.91M(+43.3%)
Jun 2023
-
-$12.26M(-5.0%)
-$93.45M(+61.3%)
Mar 2023
-
-$12.90M(-41.8%)
-$57.95M(-45.6%)
Dec 2022
-$106.62M(-22.8%)
-$22.17M(-51.9%)
-$106.62M(-7.1%)
Sep 2022
-
-$46.13M(-298.4%)
-$114.80M(+2.3%)
Jun 2022
-
$23.25M(-137.8%)
-$112.23M(-35.3%)
Mar 2022
-
-$61.57M(+102.9%)
-$173.54M(+25.6%)
Dec 2021
-$138.12M
-$30.35M(-30.3%)
-$138.12M(+16.0%)
Sep 2021
-
-$43.55M(+14.4%)
-$119.05M(+31.8%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$38.07M(+45.6%)
-$90.31M(-75.1%)
Mar 2021
-
-$26.15M(+131.8%)
-$362.32M(-374.9%)
Dec 2020
$131.81M(-387.6%)
-$11.28M(-23.8%)
$131.81M(-2.9%)
Sep 2020
-
-$14.81M(-95.2%)
$135.79M(-5.0%)
Jun 2020
-
-$310.08M(-166.3%)
$143.00M(-67.8%)
Mar 2020
-
$467.98M(-6512.4%)
$444.01M(-1068.8%)
Dec 2019
-$45.83M(-115.9%)
-$7.30M(-3.9%)
-$45.83M(-82.2%)
Sep 2019
-
-$7.60M(-16.3%)
-$257.45M(+53.9%)
Jun 2019
-
-$9.07M(-58.5%)
-$167.26M(-155.9%)
Mar 2019
-
-$21.86M(-90.0%)
$299.06M(+4.0%)
Dec 2018
$287.68M(-402.8%)
-$218.92M(-365.0%)
$287.68M(-43.2%)
Sep 2018
-
$82.60M(-81.9%)
$506.60M(+19.5%)
Jun 2018
-
$457.24M(-1475.3%)
$424.00M(-1375.3%)
Mar 2018
-
-$33.25M
-$33.25M
Dec 2017
-$95.02M(+387.4%)
-
-
Dec 2016
-$19.50M
-
-

FAQ

  • What is Amneal Pharmaceuticals annual cash flow from financing activities?
  • What is the all time high annual CFF for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals annual CFF year-on-year change?
  • What is Amneal Pharmaceuticals quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals quarterly CFF year-on-year change?
  • What is Amneal Pharmaceuticals TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals TTM CFF year-on-year change?

What is Amneal Pharmaceuticals annual cash flow from financing activities?

The current annual CFF of AMRX is -$211.79M

What is the all time high annual CFF for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high annual cash flow from financing activities is $287.68M

What is Amneal Pharmaceuticals annual CFF year-on-year change?

Over the past year, AMRX annual cash flow from financing activities has changed by +$782.00K (+0.37%)

What is Amneal Pharmaceuticals quarterly cash flow from financing activities?

The current quarterly CFF of AMRX is -$39.17M

What is the all time high quarterly CFF for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high quarterly cash flow from financing activities is $467.98M

What is Amneal Pharmaceuticals quarterly CFF year-on-year change?

Over the past year, AMRX quarterly cash flow from financing activities has changed by -$16.01M (-69.15%)

What is Amneal Pharmaceuticals TTM cash flow from financing activities?

The current TTM CFF of AMRX is -$227.80M

What is the all time high TTM CFF for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high TTM cash flow from financing activities is $506.60M

What is Amneal Pharmaceuticals TTM CFF year-on-year change?

Over the past year, AMRX TTM cash flow from financing activities has changed by -$4.97M (-2.23%)
On this page